Quark Sees Nitto Denko Deal as 'Harbinger' of Future Partnerships
August 05, 2010
Quark Sees Nitto Denko Deal as 'Harbinger' of Future Partnerships
According to a company official, future deals, as with the one with Nitto Denko, will be driven by Quark's freedom to operate in the siRNA drugs space.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.